Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 23818355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.

  2011cited by this paper
• Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.

  2010cited by this paper
• Molecular alterations associated with bladder cancer initiation and progression

  2008cited by this paper
• Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder.

  2008cited by this paper
• Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression.

  2007cited by this paper
• Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

  2006cited by this paper
• Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.

  2006cited by this paper
• Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components

  2006cited by this paper
• Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

  2005cited by this paper
• World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs

  2005cited by this paper
• Bladder cancer: epidemiology, staging and grading, and diagnosis.

  2005cited by this paper
• Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression

  2004cited by this paper
• Rosai and Ackerman’s Surgical Pathology, 9th ed.

  2004cited by this paper
• Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

  2004cited by this paper
• [Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki67].

  2003cited by this paper
• Análisis multivariado de recidiva y progresión en el carcinoma de células transicionales de vejiga en estadio T1: Valor pronóstico de p53 y ki67

  2003cited by this paper
• Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.

  2003cited by this paper
• Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer.

  2003cited by this paper
• A Population-based Study of 538 Patients with Newly Detected Urinary Bladder Neoplasms Followed during 5 Years

  2003cited by this paper
• Impact of p53 and Ki‐67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder

  2002cited by this paper
• Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network.

  2002cited by this paper
• p53 Mutation in Bladder Cancer Patients in Japan and Inhibition of Growth by in Vitro Adenovirus-Mediated Wild-Type p53 Transduction in Bladder Cancer Cells

  2001cited by this paper
• Relevance of p53 Gene Alterations for Tumor Recurrence in Patients with Superficial Transitional Cell Carcinoma of the Bladder

  2001cited by this paper
• The Ki‐67 protein: From the known and the unknown

  2000cited by this paper
• MIB‐1 as a proliferative marker in transitional cell carcinoma of the bladder

  2000cited by this paper
• Evaluation of P53 Protein Overexpression, Ki67 Proliferative Activity and Mitotic Index as Markers of Tumour Recurrence in Superficial Transitional Cell Carcinoma of the Bladder

  2000cited by this paper
• The Pathologist's Perspective

  1999cited by this paper
• Bladder. Risk and prognostic factors--a pathologist's perspective.

  1999cited by this paper
• Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

  1998cited by this paper
• The prognostic value of p53 in superficially infiltrating transitional cell carcinoma.

  1995cited by this paper
• Accumulation of nuclear p53 and tumor progression in bladder cancer.

  1994cited by this paper
• Flow cytometric DNA and p53 analysis in superficially infiltrating bladder carcinoma.

  1994cited by this paper
• The p53 tumor-suppressor gene.

  1992cited by this paper
• THE P53 TUMOR SUPPRESSOR GENE

  1991cited by this paper

• Investigation of Ki67 and Phospho-Histone H3 Expressions in Urothelial Carcinoma of the Bladder by Immunohistochemical Method

  2024cites this paper
• The prognostic effect of immunohistochemical staining rates in patients with non–muscle-invasive bladder cancer

  2023cites this paper
• A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology

  2022cites this paper
• Association of smoking, p53 and Ki-67 immunomarkers with bladder neoplasms in tribal region of India

  2022cites this paper
• Clinicopathological study of urothelial neoplasms in urinary bladder with special reference to expression of Her2/neu and Ki-67 in malignant lesions

  2021cites this paper
• Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence

  2020cites this paper
• Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer

  2019cites this paper
• Histomorphological Study of Urinary Bladder Tumor and Status of HER2/Neu and Ki67 Expression in Urothelial Carcinoma

  2019cites this paper
• Expression of PD-L 1 associated with Ki-67 and chemotherapy response but not p 53 in osteosarcoma

  2018cites this paper
• Downregulation of guanine nucleotide-binding protein beta 1 (GNB1) is associated with worsened prognosis of clearcell renal cell carcinoma and is related to VEGF signaling pathway.

  2017cites this paper
• Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget’s Disease

  2017cites this paper
• Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder

  2017cites this paper
• Overexpression of CKAP4 is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma and Functions via Cyclin B Signaling

  2017cites this paper
• Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer.

  2017cites this paper
• PROFILS MOLÉCULAIRES PRÉDICTIFS DU POTENTIEL MÉTASTATIQUE DU CARCINOME UROTHÉLIAL DE LA VESSIE DE STADE PT1 OU SUPÉRIEUR

  2017cites this paper
• Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy

  2016cites this paper
• TFPI-2 expression is decreased in bladder cancer and is related to apoptosis.

  2016cites this paper
• MKI67 (marker of proliferation Ki-67)

  2015cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2015cites this paper
• Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer

  2014cites this paper
• Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma

  2014cites this paper